GSI 255 Pill: gray , capsule/oblong, 15mm
Generic Name: emtricitabine/rilpivirine/tenofovir alafenamide
The pill with imprint GSI 255 (Gray, Capsule/Oblong1) has been identified as Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg and is used for HIV Infection. It belongs to the drug class antiviral combinations and is not a controlled substance.
Images for GSI 255
Odefsey
- Generic Name
- emtricitabine/rilpivirine/tenofovir alafenamide
- Imprint
- GSI 255
- Strength
- emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg
- Color
- Gray
- Size
- 15.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences, Inc.
- Inactive Ingredients
-
lactose monohydrate,
microcrystalline cellulose,
polysorbate 20,
croscarmellose sodium,
magnesium stearate,
water,
titanium dioxide,
magnesium silicate,
ferrosoferric oxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 61958-2101 | Gilead Sciences, Inc. |
| 54569-6645 | A-S Medication Solutions, LLC (repackager) |
See also:
More about Odefsey (emtricitabine / rilpivirine / tenofovir alafenamide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antiviral combinations
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.